What is GreenMark Biomedical?
GreenMark Biomedical is a medical technology firm specializing in the development of diagnostic and therapeutic solutions derived from food-grade starch. The company's primary innovation involves the use of sub-micron starch particles as a biocompatible carrier for medical and dental applications. Because these particles are naturally degraded by enzymes found in human saliva, they offer a safe and effective medium for targeted diagnostic imaging.
The company's flagship product, the LumiCare Caries Detection Rinse, represents a significant shift in dental care. By targeting the subsurface of carious lesions and illuminating them under a blue curing light, the technology allows dental professionals to detect, monitor, and treat dental caries without the need for invasive surgical intervention. This focus on non-surgical, preventative care addresses one of the most prevalent chronic diseases globally, providing a scalable solution for routine dental examinations.
How much funding has GreenMark Biomedical raised?
GreenMark Biomedical has raised a total of $3.5M across 3 funding rounds:
Angel/Seed
$1.2M
Grant
$1.5M
Unspecified
$830K
Angel/Seed (2019): $1.2M with participation from BlueWater Angels, Invest Michigan, Western Michigan University’s BRCC, Red Cedar Ventures, Invest Detroit Ventures, and The University of Michigan’s MINTS program
Grant (2019): $1.5M led by Small Business Development Center
Unspecified (2022): $830K supported by University of Michigan MINTS fund, Michigan Rise funds, BlueWater Angels, and Red Cedar Ventures
Key Investors in GreenMark Biomedical
Invest Michigan
Michigan's most active technology investor, supporting with capital early stage high tech companies located in Michigan.
Small Business Development Center
Americas Seed Fund, powered by the Small Business Administration, provides non-dilutive funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs to support technology-focused entrepreneurs and small businesses.
Red Cedar Ventures
A venture capital fund focused on growing Michigan State University-based startup companies and accelerating the commercialization of university-developed technologies.
What's next for GreenMark Biomedical?
With the recent infusion of $830K, GreenMark Biomedical is well-positioned to accelerate the commercial rollout of its diagnostic suite. The strategic focus will likely shift toward scaling manufacturing capabilities and expanding clinical adoption among dental practitioners. As the company moves deeper into the commercialization lifecycle, the emphasis will remain on securing regulatory milestones and broadening the application of its starch-based particle technology beyond caries detection into other areas of dental and medical diagnostics.
The continued involvement of institutional backers and university-affiliated venture funds suggests a long-term commitment to the company's research-heavy business model. Future growth will likely be driven by the integration of LumiCare into standard dental workflows, potentially establishing a new standard of care for early-stage lesion management and non-invasive treatment protocols.
